High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
BMC Neurology · 2024
DOI: 10.1186/s12883-024-03579-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Neurology, 2024. Verfasst von Tamanna Agarwal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine in Hradec Kralove, Charles University, Prague, Czech Republic. Hauptthemen laut MEDLINE: Carboxypeptidase B2, Ischemic Stroke, Thrombosis, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
The risk of acute ischemic stroke (AIS) associated with high estrogen states, including pregnant patients and those using oral contraceptives, has been well documented. We described the histological composition of thrombi collected in these cases.
Methods
From a prospective tissue registry (STRIP registry) of thrombi retrieved during mechanical thrombectomy for AIS, we identified 5 patients with high estrogen states: 1 post-partum patient, 1 undergoing hormone replacement therapy and 3 consuming oral contraceptive pills. Five male control patients were randomly chosen matched by age. Immunohistochemistry for CD42b (platelets), von Willebrand factor (vWF), thrombin-activatable fibrinolysis inhibitor (TAFI), fibrinogen and plasminogen activator inhibitor-1 (PAI-1) was performed. Expression was quantified using Orbit Image Software. Student’s t-test was performed as appropriate.
Results
Mean TAFI content for the high estrogen state group was higher than controls (25.6 ± 11.9% versus 9.3 ± 9.0%, p = 0.043*). Mean platelet content for the high estrogen state group was lower than controls (41.7 ± 10.6% versus 61.8 ± 12.9%, p = 0.029*). No significant difference was found in vWF, fibrinogen and PAI-1 expression. Mean time to recanalize was higher in the high estrogen state group compared to the control group (57.8 ± 27.6 versus 22.6 ± 11.4 min, p = 0.0351*). The mean number of passes required was higher in the high estrogen group compared to controls 4.6 versus 1.2, p = 0.0261*).
Conclusions
TAFI expression, a powerful driver of thrombosis, was significantly higher in stroke thrombi among patients with high estrogen states compared to controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine in Hradec Kralove, Charles University, Prague, Czech Republic.
- Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. mereuta.oana@mayo.edu.
- Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.
- Henry Ford Hospital, Detroit, MI, USA.
- Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Agarwal, T., Mereuta, O. M., Ghozy, S., Larco, J. L. A., Bilgin, C., Kadirvel, R., Brinjikji, W., & Kallmes, D. F. (2024). High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states. BMC Neurology. https://doi.org/10.1186/s12883-024-03579-2
Vancouver
Agarwal T, Mereuta OM, Ghozy S, Larco JLA, Bilgin C, Kadirvel R, et al. High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states. BMC Neurology. 2024. doi:10.1186/s12883-024-03579-2
BibTeX
@article{Agarwal2024,
author = {Agarwal, Tamanna and Mereuta, Oana Madalina and Ghozy, Sherief and Larco, Jorge L Arturo and Bilgin, Cem and Kadirvel, Ram and Brinjikji, Waleed and Kallmes, David F},
title = {High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states},
journal = {BMC Neurology},
year = {2024},
doi = {10.1186/s12883-024-03579-2}
}
EUVIMED